- Home
- ABTS vs AIMD Comparison
ABTS vs AIMD Comparison
Compare ABTS & AIMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ABTS | AIMD |
|---|---|---|
| Founded | 2010 | 1984 |
| Country | Hong Kong | United States |
| Employees | N/A | 44 |
| Industry | Computer Software: Programming Data Processing | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.4M | 9.8M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | ABTS | AIMD |
|---|---|---|
| Price | $2.75 | $1.48 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 1.0M | 39.8K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.35 | $0.44 |
| 52 Week High | $10.86 | $4.50 |
Technical Indicators
Market Signals| Indicator | ABTS | AIMD |
|---|---|---|
| Relative Strength Index (RSI) | 43.15 | 41.65 |
| Support Level | $2.06 | $1.26 |
| Resistance Level | $4.75 | $1.79 |
| Average True Range (ATR) | 0.31 | 0.13 |
| MACD | 0.10 | 0.01 |
| Stochastic Oscillator | 51.64 | 22.73 |
Price Performance
Historical ComparisonAbout ABTS Abits Group Inc
Abits Group Inc is a digital data center operator with bitcoin self-mining operations. The group has its subsidiaries in USA, China, Canada and Hong Kong.
About AIMD Ainos Inc.
Ainos Inc is a dual-platform AI and biotech company pioneering smelltech and immune therapeutics. Its AI Nose platform and smell language model (SLM) digitize scent into Smell ID, a machine-readable data format, powering intelligent sensing across robotics, smart factories, and healthcare. The company also develops VELDONA, a low-dose oral interferon targeting rare, autoimmune, and infectious diseases. It combines AI and Nose, redefining machine perception for the sensory age.